Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EYEG

AB Corporate Bond ETF (EYEG) Price, Holdings, & News

AB Corporate Bond ETF logo

About AB Corporate Bond ETF (NASDAQ:EYEG)

Advanced Chart

Key Stats

Today's Range
$34.52
$34.63
50-Day Range
$1.59
$2.25
52-Week Range
$33.92
$37.24
Volume
2,893 shs
Average Volume
1,377 shs
Market Capitalization
$26.62 million
Assets Under Management
$26.55 million
Dividend Yield
5.92%
Net Expense Ratio
0.30%
Aggregate Rating
N/A

ETF Overview

AB Corporate Bond ETF Expenses

TypeEYEGInvestment Grade ETFsFixed Income ETFsNASDAQ ETFsAll ETFs
Management Fee0.30%0.23%0.32%0.54%0.53%
Other Expenses0.00%0.11%0.27%0.52%0.56%
Total Expense0.30%0.25%0.40%0.74%0.73%
Fee Waiver0.00%-0.14%-0.26%-0.50%-0.63%
Net Expense0.30%0.23%0.35%0.63%0.60%
Receive EYEG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AB Corporate Bond ETF and its competitors with MarketBeat's FREE daily newsletter.

EYEG ETF News Headlines

Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…
What Economic Factors Influence Corporate Bond Yields?
BUFC AB Conservative Buffer ETF
High Yield Corporate Bonds In Emerging Markets Are Red Hot
See More Headlines

EYEG ETF - Frequently Asked Questions

AB Corporate Bond ETF (NASDAQ:EYEG) announced its quarterly earnings data on Thursday, August, 12th. The specialty pharmaceutical company reported ($0.35) EPS for the quarter, beating the consensus estimate of ($0.42) by $0.07.

AB Corporate Bond ETF (EYEG) raised $5 million in an initial public offering on Friday, February 13th 2015. The company issued 800,000 shares at a price of $6.00 per share. Aegis Capital Corp and Chardan Capital Markets acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that AB Corporate Bond ETF investors own include Bausch Health Cos (BHC), MannKind (MNKD), Bristol Myers Squibb (BMY), Sorrento Therapeutics (SRNE), Idera Pharmaceuticals (IDRA), SCYNEXIS (SCYX) and Novavax (NVAX).

Fund Details

Issuer
AllianceBernstein
Fund Name
AB Corporate Bond ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:EYEG
Inception Date
12/13/2023
Fund Manager
Timothy Kurpis, Bernd Wuebben

Fund Focus

Asset Class
Fixed Income
Benchmark
N/A
Category
Corporate
Focus
Investment Grade
Development Level
Blended Development
Region
Global
Number of Holdings
464

Fund Statistics

Assets Under Management
$26.55 million
Average Daily Volume
$0.00
Discount/Premium
0.07%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
AllianceBernstein L.P.
Custodian
State Street Bank and Trust Company
Distributor
Foreside Fund Services, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
1,300 shs

Miscellaneous

Beta
0.16
Creation Unit
50,000
Creation Fee
$250.00
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Top 10 EYEG Holdings

  • Us Long Bond(Cbt) Sep25 Xcbt 20250919
    Holding Weight: 7.88%
  • Us 5yr Note (Cbt) Sep25 Xcbt 20250930
    Holding Weight: 7.85%
  • Ultra 10 Year US Treasury Note Future Sept 25
    Holding Weight: 4.10%
  • Alliancebernstein Govt Stif Ssc Fund 64ba Agis 587
    Holding Weight: 1.69%
  • Targa Resources Corp. 6.5%
    Holding Weight: 0.49%
  • 3M Company 2.875%
    Holding Weight: 0.48%
  • 3M Company 3.375%
    Holding Weight: 0.48%
  • 7-Eleven Inc. 1.8%
    Holding Weight: 0.48%
  • Altria Group, Inc. 3.4%
    Holding Weight: 0.48%
  • Altria Group, Inc. 4.25%
    Holding Weight: 0.48%

This page (NASDAQ:EYEG) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners